The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Open accessAbstract
The malignant cells of acute promyelocytic leukemia (APL) contain a reciprocal chromosomal translocation that fuses the promyelocytic leukemia gene (PML) with the retinoic acid receptor α gene (RAR α). To test the hypothesis that the chimera PMLRAR α plays a role in leukemogenesis, we expressed a PMLRAR α cDNA in myeloid cells of transgenic mice.PMLRAR α transgenic mice exhibited impaired neutrophil maturation early in life, which progressed at a low frequency over the course of several months to overt APL. Both the preleukemic state and the leukemia could be transplanted to nontransgenic mice, and the transplanted preleukemia could progress to APL. The APL recapitulated features of the human disease, including a response to retinoic acid. Retinoic acid caused the leukemic cells to differentiate in vitro and in vivo, eliciting remissions of both the preleukemic state and APL in mice. Our results demonstrate that PMLRAR α impairs neutrophil differentiation and initiates the development of APL. The transgenic mice described here provide an apparently accurate model for human APL that includes clear evidence of tumor progression. The model should be useful for exploring the molecular pathogenesis of APL and the mechanisms of the therapeutic response to retinoic acid, as well as for preclinical studies of therapeutic regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manipulating the Mouse Embryo: A Laboratory Manual
Behringer, R. R., Gertsenstein, M., Nagy, K. V., & Nagy, A. (2002) · Cited by 2,046
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Lanotte, M., Martin-Thouvenin, V, Najman, S., Balerini, P., Valensi, F., & Berger, R. (1991) · Blood · doi:10.1182/blood.v77.5.1080.1080 · Cited by 883
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Warrell, R. P., de The, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 776
He, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia
Frankel, S. R., Eardley, A., Lauwers, G., Weiss, M., & Warrell, R. P. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-292 · Cited by 705
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA
Rowley, J., Golomb, H., & Dougherty, C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91415-5 · Cited by 633
Fleming, T. J., Fleming, M. L., & Malek, T. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2399 · Cited by 619
FVB/N: an inbred mouse strain preferable for transgenic analyses.
Taketo, M., Schroeder, A. C., Mobraaten, L. E., Gunning, K. B., Hanten, G., Fox, R. R., Roderick, T. H., Stewart, C. L., Lilly, F., & Hansen, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2065 · Cited by 598
Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 583
Self-citationAcute promyelocytic leukemia: from genetics to treatment
Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P., Donti, E., Biondi, A., Lo Coco, F., Grignani, F., & Pelicci, P. (1994) · Blood · doi:10.1182/blood.v83.1.10.10 · Cited by 494
Self-citationCharacterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells
Hestdal, K., Ruscetti, F. W., Ihle, J. N., Jacobsen, S. E., Dubois, C. M., Kopp, W. C., Longo, D. L., & Keller, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.22 · Cited by 464
Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05095.x · Cited by 415
MORTALITY IN ORAL CONTRACEPTIVE USERS
VESSEY, M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92875-0 · Cited by 394
Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J. (1997) · Blood · doi:10.1182/blood.v89.2.376 · Cited by 352
Self-citationCurrent protocols in immunology
Borek, F. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90295-5 · Cited by 322
Pandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo‐Coco, F., Grignani, F., & Pelicci, P. G. (1991) · PubMed · Cited by 305
Self-citationPMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292
bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages.
Lagasse, E., & Weissman, I. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.1047 · Cited by 274
Self-citationPandolfi, P. P., Alcalay, M., Fagioli, M., Zangrilli, D., Mencarelli, A., Diverio, D., Biondi, A., Lo Coco, F., Rambaldi, A., & Grignani, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05185.x · Cited by 262
Self-citationPML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3
Dalton, W. J., Ahearn, M., McCredie, K., Freireich, E., Stass, S., & Trujillo, J. (1988) · Blood · doi:10.1182/blood.v71.1.242.242 · Cited by 235
Robbins, S. M., Quintrell, N. A., & Bishop, J. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3507 · Cited by 233
Self-citationBorrow, J., Goddard, A. D., Gibbons, B., Katz, F. E., Swirsky, D. M., Fioretos, T., Dubé, I. D., Winfield, D. A., Kingston, J. E., Hagemeijer, A., et al. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06463.x · Cited by 155
The PML gene encodes a phosphoprotein associated with the nuclear matrix
Chang, K., Fan, Y., Andreeff, M., Liu, J., & Mu, Z. (1995) · Blood · doi:10.1182/blood.v85.12.3646.bloodjournal85123646 · Cited by 145
Immunodetection of multiple species of retinoic acid receptor α: Evidence for phosphorylation
Gaub, M. P., Rochette‐Egly, C., Lutz, Y., Ali, S., Matthes, H. W. D., Scheuer, I., & Chambon, P. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90282-d · Cited by 124
Transgenic expression of PML/RARalpha impairs myelopoiesis.
Early, E., Moore, M. A., Kakizuka, A., Nason-Burchenal, K., Martin, P., Evans, R. M., & Dmitrovsky, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7900 · Cited by 110
Rousselot, P. H., Hardas, B., Patel, A. B., Guidez, F., Gäken, J. A., Castaigné, S., Dejean, A., de Thé, H., Degos, L., & Farzaneh, F. (1994) · PubMed · Cited by 101
Huang, M., Ye, Y., Chen, S. R., Zhao, J.-W., Gu, L. J., Cai, J., Zhao, L., Xie, J., Shen, Z. X., & Wang, Z. Y. (1987) · PubMed · Cited by 96
Clinical pharmacology of all-trans retinoic acid.
Muindi, J. R., Young, C. W., & Warrell, R. P. (1994) · PubMed · Cited by 61
Achkar, C. C., Bentel, J. M., Boylan, J. F., Scher, H. I., Gudas, L. J., & Miller, W. H. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08398-9 · Cited by 60
Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice.
Grisolano, J. L., Sclar, G. M., & Ley, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8989 · Cited by 53
Cited by
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Self-citationAcute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
The role of FLT3 in haematopoietic malignancies
Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865
Metadata
- Authors
- Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-03-18
- Volume
- 94
- Issue
- 6
- Pages
- 2551-2556
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079526924
- Cited by
- 434
- References
- 37
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.